Home » Topics » BioWorld Science

BioWorld Science
RSS

FDA accepts Seelos' IND for phase IIb/III study of SLS-005 for MPS III

Aug. 23, 2019

DREAMM-2 study of belantamab mafodotin in relapsed multiple myeloma meets primary objective

Aug. 23, 2019

HMPL-523 begins phase I trial in China for ITP

Aug. 23, 2019

Sunshine Lake Pharma discovers sodium/glucose cotransporter 1 inhibitors

Aug. 23, 2019

Shanghai Hengrui Pharmaceutical, Jiangsu Hengrui Medicine disclose F2RL3 antagonists

Aug. 23, 2019

High affinity nerve growth factor receptor inhibitors patented by Shanghai GeneChem

Aug. 23, 2019

Medshine Discovery identifies Janus kinase inhibitors

Aug. 23, 2019

New tubulin polymerization inhibitors identified at the University of Sydney

Aug. 23, 2019

CARB-X funds development of vaccine against carbapenem-resistant superbug Klebsiella pneumoniae

Aug. 23, 2019

Phase I results for AZD-1775 plus gemcitabine in locally advanced pancreatic cancer

Aug. 23, 2019

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...